Janoshik 99%+Research Peptides · Metabolic & Pigment Research
Retatrutide
20 mg99%+ purity
Triple-agonist peptide studied across three receptor systems.
Triple agonistEnergy expenditureFat oxidation
€129.99
1
Tier 01
From 2×
-5%
€123.49 /unit
Tier 02
From 5×
-10%
€116.99 /unit
Tier 03
From 10×
-15%
€110.49 /unit
Discount applies to the quantity of this product in your cart.
Mechanism of action — research context
Retatrutide is studied as a next-generation metabolic peptide activating three receptors: GLP-1, GIP, and glucagon. This triple-agonist mechanism is investigated for appetite pathways, energy expenditure, and fat-oxidation signaling, with glucagon-pathway stimulation a particular focus in body-composition research.
Not for human consumption. For research purposes only. This profile summarizes documented research mechanisms and is not a medical claim, dosing instruction, or recommendation for human or animal use.